Literature DB >> 7752772

Buspirone treatment of Tourette's syndrome.

S M Dursun, J G Burke, M A Reveley.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 7752772     DOI： 10.1016/s0140-6736(95)92564-3

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  4 in total

1.  Clinical effectiveness of quetiapine in children and adolescents with Tourette's syndrome : a retrospective case-note survey.

Authors:  Mazlum Copur; Baki Arpaci; Turkay Demir; Halis Narin
Journal:  Clin Drug Investig       Date:  2007       Impact factor: 2.859

2.  Treatment strategies for tics in Tourette syndrome.

Authors:  Clare M Eddy; Hugh E Rickards; Andrea E Cavanna
Journal:  Ther Adv Neurol Disord       Date:  2011-01       Impact factor: 6.570

Review 3.  Pharmacological options for the treatment of Tourette's disorder.

Authors:  F J Jiménez-Jiménez; P J García-Ruiz
Journal:  Drugs       Date:  2001       Impact factor: 9.546

4.  European clinical guidelines for Tourette syndrome and other tic disorders. Part II: pharmacological treatment.

Authors:  Veit Roessner; Kerstin J Plessen; Aribert Rothenberger; Andrea G Ludolph; Renata Rizzo; Liselotte Skov; Gerd Strand; Jeremy S Stern; Cristiano Termine; Pieter J Hoekstra
Journal:  Eur Child Adolesc Psychiatry       Date:  2011-04       Impact factor: 4.785
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.